Pawelec G, Schneider E M, Wernet P
Eur J Immunol. 1985 Feb;15(2):163-7. doi: 10.1002/eji.1830150210.
Alloproliferative primed lymphocyte typing (PLT) clones recognizing determinants associated with HLA-DR/Dw, SB, MB, or novel "SB-like" gene products were screened for their ability to suppress lymphoproliferative responses in primary and secondary mixed lymphocyte cultures (MLC), and for their surface marker phenotypes. Two nonsuppressive HLA-D specific PLT clones were OKT4-, OKT8+ whereas all others possessed an OKT4+, OKT8-, Leu-8- phenotype. All clones secreted interleukin 2 (IL2) after specific stimulation. The eight PLT clones specific for "SB-like" antigens strongly suppressed MLC, whereas only one of 35 DR/Dw-specific, and none of 20 SB-specific PLT clones did so. Suppressive activity of such PLT clones was not restricted by major histocompatibility complex products, was radioresistant (20 Gy), and was not caused by absorption of IL2 or by cytotoxicity of the cloned cells. Suppressive clones exerted their effects directly on proliferating T cells, as assessed by their ability to prevent growth of cloned PLT cells stimulated by B cell lines, and their ability to block primary MLC even when added 96 h after the start of the 144-h culture. Culture supernatants from suppressive, but not from nonsuppressive, PLT clones also strongly and nonspecifically inhibited lymphoproliferative responses. The suppressive factor(s) was not dialyzable, not sensitive to pH 2 or heat treatment and not cytotoxic. Thus, all T cell clones proliferating against novel "SB-like" but not SB antigens, as well as rare clones specific for D region determinants, possess powerful nonspecific suppressive activities dissociated from their "helper-related" OKT4+, OKT8-, Leu 8-, IL2-secreting phenotypes.
筛选出识别与HLA - DR/Dw、SB、MB或新型“SB样”基因产物相关决定簇的同种异体增殖预致敏淋巴细胞分型(PLT)克隆,检测其在原发性和继发性混合淋巴细胞培养(MLC)中抑制淋巴细胞增殖反应的能力及其表面标志物表型。两个非抑制性的HLA - D特异性PLT克隆为OKT4 -、OKT8 +,而其他所有克隆均具有OKT4 +、OKT8 -、Leu - 8 - 表型。所有克隆在特异性刺激后均分泌白细胞介素2(IL2)。八个针对“SB样”抗原的PLT克隆强烈抑制MLC,而35个DR/Dw特异性PLT克隆中只有一个,20个SB特异性PLT克隆均无此作用。此类PLT克隆的抑制活性不受主要组织相容性复合体产物的限制,具有放射抗性(20 Gy),且不是由IL2的吸收或克隆细胞的细胞毒性引起的。通过抑制性克隆阻止B细胞系刺激的克隆PLT细胞生长的能力,以及即使在144小时培养开始96小时后添加仍能阻断原发性MLC的能力评估,抑制性克隆直接作用于增殖的T细胞。抑制性而非非抑制性PLT克隆的培养上清液也强烈且非特异性地抑制淋巴细胞增殖反应。抑制因子不可透析,对pH 2或热处理不敏感,且无细胞毒性。因此,所有针对新型“SB样”而非SB抗原增殖的T细胞克隆,以及针对D区决定簇的罕见克隆,均具有与其“辅助相关”的OKT4 +、OKT8 -、Leu 8 -、IL2分泌表型无关的强大非特异性抑制活性。